The text resize requires Javascript to be enabled. Please enable Javascript on your browser or use the browser text size controls
The interactive content on Merck.com requires the Adobe Flash Player, which you can
download for free here
.
NYSE
| MRK
40.000000
| -0.000000
4:02 PM ET | 16 May 2008
Product News
Read the latest news on Merck medicines and vaccines
Research & Development News
Read the latest news on Merck Research and Development
Corporate News
Merck Wins Appeal in VIOXX® Case
Financial News
Merck Reports First-Quarter 2008 Financial Results
Public Policy
Merck's position on key public policy issues
SINGULAIR® (montelukast)
Statement: FDA early communication on safety review of SINGULAIR
MerckVaccines.com
Direct ordering, account management, and product information
FOSAMAX® (alendronate sodium)
Statement regarding Osteonecrosis of the Jaw
VIOXX Information Center
Information on the voluntary withdrawal of VIOXX® (rofecoxib)
This U.S. Web site is subject to
Merck.com Terms of Use
RSS
Podcast